2-11207815-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2
The NM_004850.5(ROCK2):āc.2460A>Cā(p.Leu820=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,612,994 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: š 0.0070 ( 14 hom., cov: 33)
Exomes š: 0.00069 ( 10 hom. )
Consequence
ROCK2
NM_004850.5 synonymous
NM_004850.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.218
Genes affected
ROCK2 (HGNC:10252): (Rho associated coiled-coil containing protein kinase 2) The protein encoded by this gene is a serine/threonine kinase that regulates cytokinesis, smooth muscle contraction, the formation of actin stress fibers and focal adhesions, and the activation of the c-fos serum response element. This protein, which is an isozyme of ROCK1 is a target for the small GTPase Rho. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 2-11207815-T-G is Benign according to our data. Variant chr2-11207815-T-G is described in ClinVar as [Benign]. Clinvar id is 3052771.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=-0.218 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00698 (1063/152338) while in subpopulation AFR AF= 0.0243 (1011/41582). AF 95% confidence interval is 0.0231. There are 14 homozygotes in gnomad4. There are 521 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1063 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ROCK2 | NM_004850.5 | c.2460A>C | p.Leu820= | synonymous_variant | 20/33 | ENST00000315872.11 | NP_004841.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ROCK2 | ENST00000315872.11 | c.2460A>C | p.Leu820= | synonymous_variant | 20/33 | 1 | NM_004850.5 | ENSP00000317985 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00701 AC: 1067AN: 152220Hom.: 14 Cov.: 33
GnomAD3 genomes
AF:
AC:
1067
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00156 AC: 388AN: 249176Hom.: 3 AF XY: 0.00107 AC XY: 145AN XY: 135192
GnomAD3 exomes
AF:
AC:
388
AN:
249176
Hom.:
AF XY:
AC XY:
145
AN XY:
135192
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000691 AC: 1009AN: 1460656Hom.: 10 Cov.: 30 AF XY: 0.000572 AC XY: 416AN XY: 726686
GnomAD4 exome
AF:
AC:
1009
AN:
1460656
Hom.:
Cov.:
30
AF XY:
AC XY:
416
AN XY:
726686
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00698 AC: 1063AN: 152338Hom.: 14 Cov.: 33 AF XY: 0.00699 AC XY: 521AN XY: 74498
GnomAD4 genome
AF:
AC:
1063
AN:
152338
Hom.:
Cov.:
33
AF XY:
AC XY:
521
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3472
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
ROCK2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 13, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at